Chang et al., 2009 - Google Patents
Tissue engineering using autologous microcirculatory beds as vascularized bioscaffoldsChang et al., 2009
View HTML- Document ID
- 17449468129715085581
- Author
- Chang E
- Bonillas R
- El-ftesi S
- Chang E
- Ceradini D
- Vial I
- Chan D
- Joseph Michaels V
- Gurtner G
- Publication year
- Publication venue
- The FASEB Journal
External Links
Snippet
Classic tissue engineering paradigms are limited by the incorporation of a functional vasculature and a reliable means for reimplantation into the host circulation. We have developed a novel approach to overcome these obstacles using autologous explanted …
- 238000011099 tissue engineering 0 title abstract description 24
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chang et al. | Tissue engineering using autologous microcirculatory beds as vascularized bioscaffolds | |
Fathollahipour et al. | Oxygen regulation in development: lessons from embryogenesis towards tissue engineering | |
Bao et al. | Construction of a portal implantable functional tissue-engineered liver using perfusion-decellularized matrix and hepatocytes in rats | |
Struecker et al. | Liver support strategies: cutting-edge technologies | |
Perin et al. | Adult stem cell therapy in perspective | |
Tee et al. | Transplantation of engineered cardiac muscle flaps in syngeneic rats | |
Gupta et al. | Application of an endothelialized modular construct for islet transplantation in syngeneic and allogeneic immunosuppressed rat models | |
Messner et al. | Emerging technologies in organ preservation, tissue engineering and regenerative medicine: a blessing or curse for transplantation? | |
Booth et al. | Liver bioengineering: current status and future perspectives | |
Shah et al. | A thin layer of decellularized porcine myocardium for cell delivery | |
Matsumoto et al. | A GELATIN COATED COLLAGEN-POLYGLYCOLIC ACID (PGA) COMPOSITE MEMBRANE AS A DURAL SUBSTITUTE | |
Uygun et al. | Decellularization and recellularization of whole livers | |
Somuncu | Decellularization concept in regenerative medicine | |
Pan et al. | In-vivo organ engineering: Perfusion of hepatocytes in a single liver lobe scaffold of living rats | |
Michel et al. | Current progress in xenotransplantation and organ bioengineering | |
Kim et al. | Vascularization of PLGA‐based bio‐artificial beds by hypoxia‐preconditioned mesenchymal stem cells for subcutaneous xenogeneic islet transplantation | |
Mao et al. | Sustained in vivo perfusion of a re-endothelialized tissue engineered porcine liver | |
Fathi et al. | Decellularized whole-organ pre-vascularization: a novel approach for organogenesis | |
Templin et al. | Transcoronary delivery of bone marrow cells to the infarcted murine myocardium: feasibility, cellular kinetics, and improvement in cardiac function | |
Zhang et al. | Cell survival and redistribution after transplantation into damaged myocardium | |
Melgar-Lesmes et al. | Implantation of healthy matrix-embedded endothelial cells rescues dysfunctional endothelium and ischaemic tissue in liver engraftment | |
Leung et al. | Fate of modular cardiac tissue constructs in a syngeneic rat model | |
Xiao et al. | Strategies to improve the therapeutic effect of pluripotent stem cell-derived cardiomyocytes on myocardial infarction | |
Inauri et al. | Challenges and perspectives of surgical treatment of liver failure. Current status and last achievements in Georgia | |
Campo et al. | Bioengineering of a human iPSC-derived vascularized endocrine pancreas for type 1 diabetes |